A Review article on Lipid nanoparticles for targeting Anti - Tumor Drugs
International Journal on Science and Technology · 16.05.2025 · 16 (2)
DOI: 10.71097/ijsat.v16.i2.4978 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal on Science and Technology, online erschienen am 16.05.2025. Verfasst von Bhakti Sudha Pandey -. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Researchers were always coming up with new nanotechnologies to fill in gaps in the right delivery of therapeutic medications and imaging agents for Tumor therapy and diagnostics. Lipid nanoparticles, or LNPs, are acceptable particulates that are extracted from different lipids and other biochemical compounds. Their overall function is to dissolve biological barriers, or biobarriers, which enables LNPs to collect again in a specific location outside of disease-target cells for responsive therapeutics. LNPs are roughly 100 nm in size. The majority of substances with significant medicinal applications were either poisonous or insoluble in aqueous solutions, or they were unstable both chemically and physiologically. Lipid-based nanoparticles, or LBNPs, are among the most promising medication delivery systems for bioactive organic molecules. Because of its current use in chemotherapy, some chemotherapeutics have a stronger antitumor impact, revolutionizing Tumorcurement. LBNPs offer excellent temporal and thermal stability, maximum load potential, ease of preparation, low manufacturing costs, and large manufacturing output since they may be produced utilizing naturally existing sources. Additionally, combining chemotherapeutic medications with LNPs decreases curement resistance, minimizes toxicities associated with active therapeutic dosages, and increases drug concentrations in tumor cells while decreasing concentrations in normal tissue. LBNPs have been extensively researched for their potential to cureTumor, both in vivo and in vitro, with promising results in certain clinical studies. An overview of the several LBNP varieties that have been created recently, as well as their uses and contributions to various Tumorlikes, are given in this paper.
Zitieren
APA
-, B. S. P. (2025). A Review article on Lipid nanoparticles for targeting Anti - Tumor Drugs. International Journal on Science and Technology, 16(2). https://doi.org/10.71097/ijsat.v16.i2.4978
Vancouver
- BSP. A Review article on Lipid nanoparticles for targeting Anti - Tumor Drugs. International Journal on Science and Technology. 2025;16(2). doi:10.71097/ijsat.v16.i2.4978
BibTeX
@article{2025,
author = {-, Bhakti Sudha Pandey},
title = {A Review article on Lipid nanoparticles for targeting Anti - Tumor Drugs},
journal = {International Journal on Science and Technology},
year = {2025},
volume = {16},
number = {2},
doi = {10.71097/ijsat.v16.i2.4978}
}
EUVIMED